Reducing Blood Transfusion in Aortic Surgery: A Novel Approach.

[1]  V. Rao,et al.  Point-of-Care Hemostatic Testing in Cardiac SurgeryClinical Perspective , 2016 .

[2]  Y. Okita,et al.  Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. , 2016, British journal of anaesthesia.

[3]  M. Ranucci,et al.  Fibrinogen supplementation after cardiac surgery: insights from the Zero-Plasma trial (ZEPLAST). , 2016, British journal of anaesthesia.

[4]  M. Ranucci,et al.  Fibrinogen concentrate as first-line hemostatic treatment for the management of bleeding in complex cardiac surgery. , 2016, The Journal of thoracic and cardiovascular surgery.

[5]  G. Hughes,et al.  Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest. , 2016, The Journal of thoracic and cardiovascular surgery.

[6]  C. Gerrard,et al.  An Exploratory Cohort Study Comparing Prothrombin Complex Concentrate and Fresh Frozen Plasma for the Treatment of Coagulopathy After Complex Cardiac Surgery , 2015, Anesthesia and analgesia.

[7]  L. Menicanti,et al.  Randomized, Double-Blinded, Placebo-Controlled Trial of Fibrinogen Concentrate Supplementation After Complex Cardiac Surgery , 2015, Journal of the American Heart Association.

[8]  Charles C. Miller,et al.  Autologous platelet-rich plasma reduces transfusions during ascending aortic arch repair: a prospective, randomized, controlled trial. , 2015, The Annals of thoracic surgery.

[9]  Kenichi A. Tanaka,et al.  Novel approaches in management of perioperative coagulopathy , 2014, Current opinion in anaesthesiology.

[10]  M. Seeberger,et al.  Transfusion of allogeneic blood products in proximal aortic surgery with hypothermic circulatory arrest: effect of thromboelastometry-guided transfusion management. , 2013, Journal of cardiothoracic and vascular anesthesia.

[11]  Charles C. Miller,et al.  Analysis of autologous platelet-rich plasma during ascending and transverse aortic arch surgery. , 2013, The Annals of thoracic surgery.

[12]  A. Hanke,et al.  Effects of Fibrinogen Concentrate as First-line Therapy during Major Aortic Replacement Surgery: A Randomized, Placebo-controlled Trial , 2013, Anesthesiology.

[13]  A. Hanke,et al.  First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. , 2011, Anesthesiology.

[14]  B. Phillips-Bute,et al.  Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest. , 2011, The Journal of thoracic and cardiovascular surgery.

[15]  M. Luehr,et al.  Pulmonary complications after descending thoracic and thoracoabdominal aortic aneurysm repair: predictors, prevention, and treatment. , 2007, The Annals of thoracic surgery.

[16]  J. Bavaria,et al.  Clinical predictors for mortality in adults undergoing thoracic aortic surgery requiring deep hypothermic circulatory arrest. , 2006, Annals of cardiac anaesthesia.

[17]  N. Rahe-meyer,et al.  Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery. , 2011, Thrombosis research.